Cargando…
Clinical outcomes in men with prostate cancer who selected active surveillance using a clinical cell cycle risk score
AIM: To evaluate active surveillance (AS) selection, safety and durability among men with low-risk prostate cancer assessed using the clinical cell cycle risk (CCR) score, a combined clinical and molecular score. PATIENTS & METHODS: Initial treatment selection (AS vs treatment) and duration of A...
Autores principales: | Kaul, Sanjeev, Wojno, Kirk J, Stone, Steven, Evans, Brent, Bernhisel, Ryan, Meek, Stephanie, D’Anna, Richard E, Ferguson, Jeffrey, Glaser, Jeffrey, Morgan, Todd M, Lieb, Jeremy, Yan, Robert, Cohen, Todd, Ehdaie, Behfar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7447833/ https://www.ncbi.nlm.nih.gov/pubmed/31483217 http://dx.doi.org/10.2217/pme-2019-0084 |
Ejemplares similares
-
Active surveillance for prostate cancer
por: Shill, Daniela K., et al.
Publicado: (2021) -
Active Surveillance for Men Younger than 60 Years or with Intermediate-risk Localized Prostate Cancer. Descriptive Analyses of Clinical Practice in the Movember GAP3 Initiative
por: Remmers, Sebastiaan, et al.
Publicado: (2022) -
Molecular markers in transitional cell carcinoma of the bladder: New insights into mechanisms and prognosis
por: Ehdaie, Behfar, et al.
Publicado: (2008) -
Patient Perceptions of a Decision Support Tool for Men with Localized Prostate Cancer
por: Austria, Mia, et al.
Publicado: (2023) -
Social ecological influences on treatment decision‐making in men diagnosed with low risk, localised prostate cancer
por: McIntosh, Megan, et al.
Publicado: (2022)